Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements
- 1 October 1999
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (10) , 1788-1792
- https://doi.org/10.1038/sj.gt.3300999
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 14 references indexed in Scilit:
- Rapid retroviral infection of human haemopoietic cells of different lineages: efficient transfer in fresh T cellsBritish Journal of Haematology, 1998
- Highly‐efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectinBritish Journal of Haematology, 1998
- Impact of a new generation of gene transfer markers on gene therapyGene Therapy, 1998
- Selective Immunoaffinity-Based Enrichment of CD34+Cells Transduced with Retroviral Vectors Containing an Intracytoplasmatically Truncated Version of the Human Low-Affinity Nerve Growth Factor Receptor (ΔLNGFR) GeneHuman Gene Therapy, 1997
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector.Proceedings of the National Academy of Sciences, 1996
- Gene Therapy for AIDS Using Retroviral Mediated Gene Transfer to Deliver HIV-1 Antisense TAR and Transdominant Rev Protein Genes to Syngeneic Lymphocytes in HIV-1 Infected Identical Twins. National Institutes of Health, Bethesda, MarylandHuman Gene Therapy, 1996
- T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 YearsScience, 1995
- High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes.Proceedings of the National Academy of Sciences, 1995
- Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferationThe Lancet, 1995